Kobo Biotech Stock Performance

as on April 21, 2026 at 9:31 pm IST

Day's Low
Day's High
₹2.73
Day's Price Range
₹3.01
₹2.99
8.70%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
₹1.99
52-Week Price Range
₹3.58
₹2.99
33.44%
Downside
19.73%
Upside

Kobo Biotech share price movements today

Previous Close: ₹2.87
Open: ₹2.87
Volume: 35.46K
Upper Circuit: ₹3.01
Lower Circuit: ₹2.73
Day's Low - High: ₹2.73 - ₹3.01
52 Week Low - High: ₹1.99 - ₹3.58

Kobo Biotech Historical Returns

1 Month Return: + 31.72 %
3 Month Return: + 37.79 %
1 Year Return: -3.55 %
3 Year Return: + 16.8 %
5 Year Return: -50.98 %

Kobo Biotech Fundamentals

as on April 21, 2026 at 4:01 pm IST

Market Cap

₹7.12 Cr

Return on Equity (ROE)

PE Ratio (TTM)

Return on capital employed (ROCE)

Beta (LTM)

0.54

P/B Ratio

-0.04

Dividend Yield

PEG Ratio

Quarterly Earnings Growth YOY

8.13

EPS (TTM)

Sector

Pharmaceuticals

Book Value

Kobo Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kobo Biotech with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Kobo Biotech Ltd	NA	7.12	-10.2%	0.00	-6	NA
NGL Fine Chem Ltd	NA	1,395.44	4.16%	0.61	21	368
Brawn Biotech Ltd	NA	6.72	-1.94%	0.00	-2	13
Marksans Pharma Ltd	BUY	8,010.58	30.76%	0.56	382	2,622
Nectar Lifescience Ltd	NA	236.42	-10.67%	0.69	-114	1,669

See all

Kobo Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Other Income	0.02	-	-	-	0.02
Total Income	0.02	-	-	-	0.02
Expenses	0.23	0.2	0.2	0.25	0.34
Operating Profit	-0.23	-0.2	-0.2	-0.25	-0.34
Profit Before Interest, Tax and Depreciation	-0.21	-0.2	-0.2	-0.25	-0.32
Depreciation	1.01	1.02	1.03	1.01	1.01
Profit Before Tax	-1.22	-1.22	-1.23	-1.26	-1.33
Profit After Tax	-1.23	-1.22	-1.23	-1.26	-1.33
Total Net profit including share of profit / Loss from associate company	-1.23	-1.22	-1.23	-1.26	-1.33
EPS	-0.51	-0.51	-0.52	-0.53	-0.56
Actual EPS	-0.51	-0.51	-0.52	-0.53	-0.56
Adjusted EPS	-0.51	-0.51	-0.52	-0.53	-0.56
Diluted EPS	-0.51	-0.51	-0.52	-0.53	-0.56

Kobo Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Other Income	0.04	0.03	0.03	0.04	0.02	0.02	0.02
Total Income	0.04	0.03	0.03	0.04	0.02	0.02	0.02
Expenses	3.02	3.9	0.69	2.79	10.5	1.5	0.87
Operating Profit	-3.02	-3.9	-0.69	-2.79	-10.5	-1.5	-0.87
Profit Before Interest, Tax and Depreciation	-2.98	-3.87	-0.65	-2.75	-10.49	-1.48	-0.86
Interest	14.5	14.44	14.47	10.84	0.13	-	-
Depreciation	6.45	6.15	5.88	5.64	4.61	4.07	4.07
Profit Before Tax	-23.93	-24.46	-21	-19.23	-15.23	-5.55	-4.93
Profit After Tax	-23.92	-24.46	-21.01	-19.23	-15.23	-5.55	-4.93
Total Net profit including share of profit / Loss from associate company	-23.92	-24.46	-21.01	-19.23	-15.23	-5.55	-4.93
EPS	-10.04	-10.27	-8.82	-8.07	-6.39	-2.33	-2.07
Actual EPS	-10.04	-10.27	-8.82	-8.07	-6.39	-2.33	-2.07
Adjusted EPS	-10.04	-10.27	-8.82	-8.07	-6.39	-2.33	-2.07
Diluted EPS	-10.04	-10.27	-8.82	-8.07	-6.39	-2.33	-2.07

Kobo Biotech Ltd Cash Flow

Figures in Rupees Crores

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Cash from Operating Activities	5.62	32.3	31.47	20.95	14.48	2.51	93.76	0.87
Cash Flow from Investing Activities	-	-	-	-	-	-	25.09	-
Cash Flow from Financing Activities	-5.26	-32.77	-31.47	-20.94	-14.47	-1.08	-120.28	-0.87
Net Cash Flow	0.35	-0.46	-	-	-	1.43	-1.43	-

Kobo Biotech Stock Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%	44.95%
DII	0.66%	0.66%	0.66%	0.66%	0%	0%	0%	0%	0%	0%	0%	0%
Public	54.39%	54.39%	54.39%	54.39%	55.05%	55.05%	55.05%	55.05%	55.05%	55.05%	55.05%	55.05%
Total Outstanding Shares	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000	2,38,25,000
Total Shareholders	6,458	6,478	6,530	6,767	6,788	6,916	7,542	7,873	7,929	7,947	7,970	7,977

Insights on Kobo Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, Kobo Biotech stock has moved up by 14.8%
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 55.05% of holdings in Mar 2026 quarter
NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 28.8% return, outperforming this stock by 36.2%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.95% of holdings in Mar 2026 quarter
NO EFFECT
Against Peers
In the last 3 years, Lupin Ltd has given 235.0% return, outperforming this stock by 224.6%

About Kobo Biotech Ltd

Avon Organics, a company set-up by P.R. Agarwal Rajesh Agarwal and G.S. Sidhu and incorporated in August 1993, specializes in manufacturing diketene & its derivatives like Monomethyl Acetoncetamide (MMA) and Methyl Acetoacetate (MAA). The company’s 1200 TPA Diketene manufacturing facility is based in Andhra Pradesh and its products have application in pigments, pharmaceuticals and pesticides. The company has technical knowhow agreement agreements in place with Shanghai Machinery & Equipment Import & Export Corporation, Xytel Technologies Partnership USA and Shanghai Peng Pu Chemical works. It has also been awarded Best New Product manufactured in the State of Andhra Pradesh by the Federation of Andhra Pradesh Chamber of Commerce and Industry and certified ISO 9002 by ANSIRAB. In addition to this, Avon Organics is also involved in Biotechnology and has a plant in Solapur, Maharashtra with an installed capacity of 150 MT. It has signed long term export contracts of Pseudoephedrine, gotten FDA approval and is about to introduce two new high value added intermediates in its Diketene division. All said, it is expected to add an additional turnover of Rs. 12 crores in 200506.

Revenue: ₹0.00Cr as on June 2024 (Q1 FY25)
Net Profit: ₹-1.33Cr as on June 2024 (Q1 FY25)
Chairperson Name: Ajit Kamath

Organisation	Kobo Biotech Ltd
Headquarters	Mumbai
Industry	Pharmaceuticals
CEO	Ajit Kamath
E-voting on shares	Click here to vote

FAQs

What is Kobo Biotech share price today?

Kobo Biotech share price today stands at ₹2.99 as on April 21, 2026 at 4:01 pm IST at the close of the market. Kobo Biotech share today touched a day high of ₹3.01 and a low of ₹2.73.

What is the 52 week high and 52 week low range for Kobo Biotech share?

Kobo Biotech touched a 52 week high of ₹3.58 and a 52 week low of ₹1.99. Kobo Biotech share price today i.e. April 21, 2026 at 4:01 pm IST is closed at ₹2.99, which is -16.48% down from its 52 week high and 50.25% up from its 52 week low.

What is Kobo Biotech's market capitalisation today?

Kobo Biotech market capitalisation is ₹7.12 Cr as on April 21, 2026 at 4:01 pm IST.

How to buy Kobo Biotech shares?

To buy Kobo Biotech shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for 531541 or Kobo Biotech Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Kobo Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kobo Biotech trading volume today?

Kobo Biotech trading volume is 35.46K as on April 21, 2026 at 4:01 pm IST. This means that 35.46K shares of Kobo Biotech were bought and sold on the stock market during today's trading session.